Abbott Laboratories ROA 2006-2018 | ABT

Current and historical return on assets (ROA) values for Abbott Laboratories (ABT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Abbott Laboratories ROA for the three months ending September 30, 2018 was 6.95%.
Abbott Laboratories ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $0.89B $71.64B 1.23%
2018-06-30 $0.93B $68.42B 1.29%
2018-03-31 $0.48B $70.91B 0.66%
2017-12-31 $0.48B $76.25B 0.66%
2017-09-30 $2.10B $72.25B 3.15%
2017-06-30 $1.17B $71.15B 2.00%
2017-03-31 $1.50B $70.89B 2.96%
2016-12-31 $1.40B $52.67B 3.26%
2016-09-30 $1.37B $39.50B 3.42%
2016-06-30 $2.28B $39.83B 5.61%
2016-03-31 $2.45B $39.64B 5.87%
2015-12-31 $4.42B $41.25B 10.40%
2015-09-30 $4.56B $41.73B 10.72%
2015-06-30 $4.52B $44.13B 10.57%
2015-03-31 $4.20B $43.10B 9.99%
2014-12-31 $2.28B $41.21B 5.48%
2014-09-30 $1.97B $42.51B 4.67%
2014-06-30 $2.40B $41.48B 5.63%
2014-03-31 $2.41B $41.66B 5.61%
2013-12-31 $2.58B $42.95B 5.97%
2013-09-30 $3.04B $44.13B 6.17%
2013-06-30 $4.02B $42.90B 7.43%
2013-03-31 $5.27B $42.69B 8.96%
2012-12-31 $5.96B $67.24B 9.36%
2012-09-30 $6.53B $63.26B 10.54%
2012-06-30 $4.89B $61.86B 8.01%
2012-03-31 $5.11B $62.42B 8.36%
2011-12-31 $4.73B $60.28B 7.77%
2011-09-30 $4.55B $59.63B 7.47%
2011-06-30 $5.14B $62.00B 8.51%
2011-03-31 $4.49B $61.65B 7.71%
2010-12-31 $4.63B $60.57B 8.24%
2010-09-30 $4.73B $57.37B 8.72%
2010-06-30 $5.31B $53.38B 10.16%
2010-03-31 $5.31B $53.36B 10.44%
2009-12-31 $5.75B $52.58B 11.76%
2009-09-30 $5.74B $49.85B 12.39%
2009-06-30 $5.35B $47.63B 12.07%
2009-03-31 $5.38B $45.44B 12.39%
2008-12-31 $4.88B $42.42B 11.52%
2008-09-30 $4.55B $41.75B 10.91%
2008-06-30 $4.18B $44.07B 10.28%
2008-03-31 $3.85B $41.18B 9.89%
2007-12-31 $3.61B $39.71B 9.57%
2007-09-30 $1.93B $37.62B 5.24%
2007-06-30 $1.93B $37.15B 5.39%
2007-03-31 $1.55B $36.29B 4.43%
2006-12-31 $1.72B $36.18B 5.20%
2006-09-30 $3.17B $33.30B 10.14%
2006-06-30 $3.13B $34.06B 10.40%
2006-03-31 $3.40B $28.53B 11.89%
2005-12-31 $3.37B $29.14B 11.76%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $121.907B $27.390B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $124.396B 19.07
Stryker (SYK) United States $62.115B 23.41
Boston Scientific (BSX) United States $50.107B 25.32
Baxter (BAX) United States $33.967B 21.93
Zimmer Biomet Holdings (ZBH) United States $22.913B 14.86
Smith & Nephew SNATS (SNN) United Kingdom $16.016B 0.00
ResMed (RMD) United States $14.484B 27.62
Perrigo (PRGO) Ireland $8.621B 13.09
Bio-Rad Laboratories (BIO) United States $8.038B 51.40
Canopy Growth (CGC) Canada $7.963B 0.00
Hill-Rom Holdings (HRC) United States $6.061B 19.22
Aurora Cannabis (ACB) Canada $5.941B 32.42
Haemonetics (HAE) United States $5.495B 48.32
Hutchison China MediTech (HCM) China $5.011B 0.00
Insulet (PODD) United States $4.690B 0.00
ICU Medical (ICUI) United States $4.600B 25.63
GW Pharmaceuticals (GWPH) United Kingdom $3.898B 0.00
Agios Pharmaceuticals (AGIO) United States $3.709B 0.00
National Vision Holdings (EYE) United States $3.224B 62.36
Neogen (NEOG) United States $3.190B 48.31
NuVasive (NUVA) United States $3.045B 28.33
Quidel (QDEL) United States $2.390B 31.16
Aphria (APHA) $2.383B 0.00
NxStage Medical (NXTM) United States $1.935B 0.00
Phibro Animal Health (PAHC) United States $1.455B 20.60
AtriCure (ATRC) United States $1.189B 0.00
Cardiovascular Systems (CSII) United States $1.007B 1450.50
VAREX IMAGING (VREX) United States $0.933B 18.74
Meridian Bioscience (VIVO) United States $0.816B 26.01
Surmodics (SRDX) United States $0.775B 118.39
OraSure Technologies (OSUR) United States $0.771B 43.38
Eagle Pharmaceuticals (EGRX) United States $0.738B 23.67
PetIQ (PETQ) United States $0.737B 20.93
MacroGenics (MGNX) United States $0.702B 0.00
Cerus (CERS) United States $0.685B 0.00
Lantheus Holdings (LNTH) United States $0.604B 18.68
Omeros (OMER) United States $0.569B 0.00
Owens & Minor (OMI) United States $0.550B 6.22
Insys Therapeutics (INSY) United States $0.531B 0.00
LeMaitre Vascular (LMAT) United States $0.510B 25.05
NanoString Technologies (NSTG) United States $0.478B 0.00
TG Therapeutics (TGTX) United States $0.429B 0.00
Evolus (EOLS) United States $0.373B 0.00
Quanterix (QTRX) United States $0.361B 0.00
Utah Medical Products (UTMD) United States $0.326B 21.11
Cytosorbents (CTSO) United States $0.287B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.254B 0.00
Rockwell Medical (RMTI) United States $0.230B 0.00
Surface Oncology (SURF) United States $0.218B 0.00
BioLife Solutions (BLFS) United States $0.197B 265.75
Bovie Medical (BVX) United States $0.189B 0.00
Chimerix (CMRX) United States $0.168B 0.00
Fonar (FONR) United States $0.141B 7.07
Conatus Pharmaceuticals (CNAT) United States $0.138B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.107B 0.00
Chembio Diagnostics (CEMI) United States $0.099B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.077B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.068B 21.53
InfuSystems Holdings (INFU) United States $0.067B 0.00
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.047B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.027B 0.00
Myomo (MYO) United States $0.024B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Valeritas Holdings (VLRX) United States $0.017B 0.00
Senestech (SNES) United States $0.017B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.000B 0.00